Profile picture of Mark Pinkham

A/Prof Mark Pinkham

BM, BCh, MA(Hons)(Oxon), FRANZCR
Radiation Oncologist
Become a Patient

I am a compassionate and detail-orientated radiation oncologist, aiming to deliver high-quality cancer care with a strong emphasis on multidisciplinary collaboration and clinical trials.


A/Prof Mark Pinkham is an experienced radiation oncologist and Adjunct Professor at Queensland University of Technology (QUT), consulting at Icon Cancer Centre North Lakes and Greenslopes Private Hospital. He is also a Staff Specialist at the Gamma Knife Centre of Queensland at the Princess Alexandra Hospital where he is the Director of Radiation Oncology Research.

He graduated from The University of Oxford, UK, in 2005 and completed a Masters in Physiological Sciences with a focus on the neurosciences in 2002. Subsequently he completed specialist training in Brisbane in 2014 and then undertook an 18-month Clinical Oncology sub-specialty fellowship in neuro-oncology and intracranial stereotactic radiosurgery (SRS) at the world-renowned Christie Hospital, UK.

He has a strong clinical and research interest in melanoma and diseases of the central nervous system including brain metastases. He is involved in the conduct and management of a number of studies in these fields, having acquired over AU$12 million in competitive research funding and grants to date. He is a member of the Scientific Advisory Committee within the Co-operative Trials Group for Neuro-Oncology (COGNO), Clinical Lead for the national eVIQ brain metastases treatment protocols and Chair of the SRS working group within TROG, which aims to establish universal quality assurance standards for radiosurgery trials across Australia and New Zealand.

He enjoys teaching through his roles as an examiner of medical trainees at the national level within the Royal Australian and New Zealand College of Radiologists (RANZCR) and research supervisor to post-graduate Masters and PhD students at QUT.

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • International Stereotactic Radiosurgery Society (ISRS)
  • Trans Tasman Radiation Oncology Group (TROG)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)
  • Australia and New Zealand Melanoma Trials Group (ANZMTG)
  • Adjunct Professor, Queensland University of Technology (QUT)
  • Senior Lecturer, University of Queensland (UQ)

Special Interests

A/Prof Mark Pinkham accepts referrals for all cancer types, with a special clinical interest in:
  • Brain cancer and spinal (CNS)
  • Lung cancer
  • Melanoma
  • Stereotactic radiation therapy

Icon Locations

North Lakes View centre
Greenslopes View centre

Visiting Locations

  • Brisbane Private Hospital
  • Mater Private Hospital, South Brisbane
  • St Andrews War Memorial Hospital
  • Princess Alexandra Hospital


  • Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases. Amelia Jardim, Justin Scott, Zachery Drew, Matthew Foote, Ananthababu P. Sadasivan, Bruce Hall, Sarah L. Olson, Mihir Shanker, Mark Pinkham. Journal of Neuro-Oncology, 2019; 145(3): 581-585.

  • Advances in radiotherapy technology for prostate cancer: What every GP should know. Peter Gorayski, Mark B. Pinkham, Margot Lehman. Australian Family Physician, 2015; 44(9): 663-667.

  • Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery. Luke Nicholls, Mark Pinkham, Anne Bernard, R. Lusk, T. Watkins, Bruce Hall, Sarah L. Olson, Matthew Foote. Clinical Oncology, 2019; 31(1), 34-40.

  • Outcomes treating stage III non‐small cell lung carcinoma with curative‐intent radiotherapy and concurrent carboplatin‐paclitaxel chemotherapy. Hon Trinh, Mark Pinkham, Margot Lehman, Dannie Zarate, Margaret Dauth, Margaret McGrath, Elizabeth McCaffrey, Gang Tao Mai, Keith Horwood. The Clinical Respiratory Journal, 2014; 10(4): 428-434.

  • Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis. Mihir Shanker, Benjamin Chua, Catherine Bettington, Matthew Foote, Mark Pinkham. Neuro-Oncology Practice, 2019; 6(2): 144-155.

View all